er f) Ændringer i lungefunktionen og behov for at kontrollere lungefunktionen
ho e) Magnitude of titration steps and resulting precautions f) The change in pulmonary function and the need for pulmonary function monitoring g) Smoking in relation to induced alteration in pharmacokinetics